Eledon Pharmaceuticals, Inc. (ELDN) vs Surrozen, Inc. (SRZN)
A side-by-side comparison of Eledon Pharmaceuticals, Inc. and Surrozen, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ELDN
Eledon Pharmaceuticals, Inc.
$2.45HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
SRZN
Surrozen, Inc.
$26.37HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ELDN vs SRZN
growth of $100 · dividends reinvested · last 6yELDN -83.3% (-25.8%/yr)SRZN -80.8% (-24.0%/yr)SRZN compounded faster over this window
ELDN SRZN
ELDN vs SRZN: by the numbers
- •SRZN is the larger company ($197M vs $189M market cap).
- •Both run net losses; ELDN's is the smaller (0.00% vs -2885.33% net margin).
Metrics side by side
Valuation
| Metric | ELDN | SRZN |
|---|---|---|
| P/S ratio | N/A | 17.13 |
| P/B ratio | 5.73 | N/A |
Profitability
| Metric | ELDN | SRZN |
|---|---|---|
| Gross margin | 0.00% | 84.56% |
| Operating margin | 0.00% | -1210.58% |
| Net margin | 0.00% | -2885.33% |
| ROE | -136.83% | N/A |
| ROIC | -74.02% | -41.61% |
Growth (annualized)
| Metric | ELDN | SRZN |
|---|---|---|
| Total return CAGR (5Y) | -15.17% | -20.80% |
Frequently asked
- How have ELDN and SRZN total returns compared?
- Over the past 5 years, ELDN delivered -15.17% and SRZN delivered -20.80% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.